Carcinoembryonic antigen levels correlated with advanced disease in medullary thyroid cancer
Abstract Background Medullary thyroid cancer (MTC) cells are capable of secreting various tumor markers including calcitonin and carcinoembyronic antigen (CEA). The purpose of this study is to determine whether abnormal CEA levels may be used as a tumor marker to predict the severity of disease in M...
Main Authors: | Sena Turkdogan, Véronique-Isabelle Forest, Michael P. Hier, Michael Tamilia, Anca Florea, Richard J. Payne |
---|---|
Format: | Article |
Language: | English |
Published: |
SAGE Publications
2018-09-01
|
Series: | Journal of Otolaryngology - Head and Neck Surgery |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s40463-018-0303-x |
Similar Items
-
Management of medullary thyroid cancer based on variation of carcinoembryonic antigen and calcitonin
by: Bo Wang, et al.
Published: (2024-10-01) -
Serum Biochemical Markers for Medullary Thyroid Carcinoma: An Update
by: Liu S, et al.
Published: (2024-04-01) -
Elevated procalcitonin levels can occur in bacterial infections and also in medullary thyroid carcinoma
by: Fatih Kaya, et al.
Published: (2024-06-01) -
A Review of the Significance in Measuring Preoperative and Postoperative Carcinoembryonic Antigen (CEA) Values in Patients with Medullary Thyroid Carcinoma (MTC)
by: Ioannis Passos, et al.
Published: (2021-06-01) -
Exploring the application value of pro‐gastrin‐releasing peptide in the clinical diagnosis and surgical treatment of medullary thyroid carcinoma
by: Qiang Miao, et al.
Published: (2023-10-01)